Erste Asset Management Gmb H Intercept Pharmaceuticals, Inc. Transaction History

Erste Asset Management Gmb H

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Nov 26, 2024	SELL	$11.23 - $19.59 $156,658 - $273,280	-13,950 Closed	0 $0
Q1 2021 Nov 22, 2024	SELL	$19.33 - $37.75 $0 - $0	0 Closed	0 $0
Q4 2020 Nov 22, 2024	BUY	$24.48 - $42.47 $0 - $0	0 New	0 $0
Q3 2020 Nov 22, 2024	BUY	$39.09 - $53.44 $0 - $0	0 New	0 $0
Q2 2020 Nov 22, 2024	BUY	$46.7 - $92.04 $0 - $0	0 New	0 $0
Q1 2020 Nov 22, 2024	BUY	$48.35 - $118.68 $0 - $0	0 New	0 $0
Q4 2019 Nov 22, 2024	BUY	$57.36 - $124.1 $0 - $0	0 New	0 $0
Q3 2019 Nov 22, 2024	BUY	$58.69 - $80.46 $0 - $0	0 New	0 $0
Q2 2019 Nov 22, 2024	BUY	$77.77 - $120.68 $0 - $0	0 New	0 $0
Q1 2019 Nov 22, 2024	BUY	$91.83 - $120.68 $0 - $0	0 New	0 $0
Q4 2018 Nov 26, 2024	BUY	$85.79 - $126.46 $1.2 Million - $1.76 Million	13,950 New	13,950 $1.3 Billion

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.